Bristol Youth Academy Counselor Medicare: Not Enrolled in Medicare Practice Location: 12422 Nw G T Revell Rd, Bristol, FL 32321 Phone: 850-643-4600 Fax: 850-643-2061 |
Apalachee Center Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 13888 Nw County Road 12, Bristol, FL 32321 Phone: 850-643-2232 Fax: 850-643-5657 |
Twin Oaks Juvenile Development, Inc Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11939 Nw State Road 20, Bristol, FL 32321 Phone: 850-643-1090 Fax: 850-643-1091 |
Community Wellness Counseling And Support Services Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 12958 Nw Collins Hill Ln, Bristol, FL 32321 Phone: 850-643-7724 Fax: 850-643-5066 |
News Archive
A University of Colorado Cancer Center study takes a new approach to killing cancer: Why not fry it into oblivion with vibrating gold nanoparticles? "But what about the frickin' lasers?" you may ask. Don't worry. There are lasers. And bioluminescence too.
Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc., and BioDelivery Sciences International, Inc. announced today that the companies have completed interim analyses of both the opioid naive and opioid experienced Phase III trials for BEMA Buprenorphine.
Mylan Inc. (Nasdaq: MYL), one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world's first trastuzumab biosimilar in India.
In people with high cholesterol levels, the fat that is built up in the artery walls narrows the arteries causing a condition called atherosclerosis. A study published on 19th June in the European Heart Journal has found the likelihood of a vaccine that can immunize humans having atherosclerosis, subsequent to successful outcomes in a mouse model study. At present, phase I clinical trial has begun in patients to see the possibility of translating the study findings to humans.
Researchers from Switzerland recently presented the results of a longitudinal cohort study they conducted in the city of Zurich. The prospective cohort study's key objective was to analyze the longitudinal changes in SARS-CoV-2 seroprevalence and assess the clustering of seropositive children in school classes from June to November 2020 in Zurich, Switzerland.
› Verified 6 days ago